18:25 EST Vanda trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VNDA:
- Vanda Pharmaceuticals announces FDA approval of Bysanti tablets
- Vanda trading halted, news pending
- Vanda Board Approves 2025 Bonuses and 2026 Compensation
- FDA Calendar: Vanda Stock (VNDA) Shows 125% Upside with Bysanti Decision on Deck
- Regulatory Hurdles Cloud Vanda Pharmaceuticals’ Prospects for Bysanti and Imsidolimab FDA Approvals